Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisca Vazquez

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Nature Reviews. Cancer|October 29, 2024
The present and future of the Cancer Dependency MapRand Arafeh, Tsukasa Shibue, Joshua M Dempster, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2008
A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTENMeghdad Rahdar, Takanari Inoue, Tobias Meyer, et al.
Cancer Cell|September 6, 2003
TSC2 regulates VEGF through mTOR-dependent and -independent pathwaysJames B Brugarolas, Francisca Vazquez, Archana Reddy, et al.
The Journal of Biological Chemistry|February 7, 2004
Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxisMiho Iijima, Yi Elaine Huang, Hongbo R Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Tumor suppressor PTEN acts through dynamic interaction with the plasma membraneFrancisca Vazquez, Satomi Matsuoka, William R Sellers, et al.
Nature|November 30, 2007
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complexJohn T Cunningham, Joseph T Rodgers, Daniel H Arlow, et al.
Molecular Cancer Research : MCR|November 20, 2015
Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted TherapyHugh S Gannon, Nathan Kaplan, Aviad Tsherniak, et al.
Nucleic Acids Research|February 11, 2004
A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screensAndrew C Hsieh, Ronghai Bo, Judith Manola, et al.
The Journal of Clinical Investigation|January 14, 2020
H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAPChi Luo, Eduardo Balsa, Elizabeth A Perry, et al.
Genome Biology|September 5, 2024
Author Correction: A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening dataAlessandro Vinceti, Rafaele M Iannuzzi, Isabella Boyle, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Nature Reviews. Cancer|October 29, 2024
The present and future of the Cancer Dependency MapRand Arafeh, Tsukasa Shibue, Joshua M Dempster, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2008
A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTENMeghdad Rahdar, Takanari Inoue, Tobias Meyer, et al.
Cancer Cell|September 6, 2003
TSC2 regulates VEGF through mTOR-dependent and -independent pathwaysJames B Brugarolas, Francisca Vazquez, Archana Reddy, et al.
The Journal of Biological Chemistry|February 7, 2004
Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxisMiho Iijima, Yi Elaine Huang, Hongbo R Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Tumor suppressor PTEN acts through dynamic interaction with the plasma membraneFrancisca Vazquez, Satomi Matsuoka, William R Sellers, et al.
Nature|November 30, 2007
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complexJohn T Cunningham, Joseph T Rodgers, Daniel H Arlow, et al.
Molecular Cancer Research : MCR|November 20, 2015
Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted TherapyHugh S Gannon, Nathan Kaplan, Aviad Tsherniak, et al.
Nucleic Acids Research|February 11, 2004
A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screensAndrew C Hsieh, Ronghai Bo, Judith Manola, et al.
The Journal of Clinical Investigation|January 14, 2020
H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAPChi Luo, Eduardo Balsa, Elizabeth A Perry, et al.
Genome Biology|September 5, 2024
Author Correction: A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening dataAlessandro Vinceti, Rafaele M Iannuzzi, Isabella Boyle, et al.
Pageof 12